KemPharm Story

KMPHDelisted Stock  USD 5.81  0.02  0.34%   
Under 62% of KemPharm's investor base is looking to short. The analysis of current outlook of investing in KemPharm suggests that many traders are alarmed regarding KemPharm's prospects. KemPharm's investor sentiment overview provides quick insight into current market opportunities from investing in KemPharm. The current market sentiment, together with KemPharm's historical and current headlines, can help investors time the market. In addition, many technical investors use KemPharm stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
KemPharm stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of KemPharm daily returns and investor perception about the current price of KemPharm as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for KemPharm.

KemPharm Latest Timeline

KemPharm is listed for 5.81. About 18.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. KemPharm recorded a loss per share of 0.91. The entity last dividend was issued on the 28th of December 2020. The firm had 1:16 split on the 28th of December 2020.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in KemPharm Stock

If you are still planning to invest in KemPharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KemPharm's history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance